Global Access & Impact

Closely aligned with SITC’s DEI core value, the society continues to expand dedicated education for the global immuno-oncology community. In 2023, SITC was honored to host the 5th World Immunotherapy Council (WIC) program to support early career investigators from around
the world. 

Global Immunotherapy Access

SITC welcomes scientists and clinicians throughout the world as it works to eradicate cancer using immunotherapies. With a commitment to breaking down barriers to critical educational programming and membership benefits, the society created cost-effective opportunities for those who reside in low- and lower-middle income economies. These initiatives are spearheaded by the SITC Global Access and Impact Committee.


David Kaufman, MD, PhD 
Third Rock Ventures
Global Access and Impact Committee Chair

Expanding Access to Cellular and Bispecific Therapies

To support expanded access to novel cellular and bispecific therapies, SITC collaborated with the Association of Community Cancer Centers (ACCC) to develop considerations and recommendations for community cancer centers interested in offering these therapies to their patients. The document is intended to serve as a resource when starting a program and helps provide a platform for what to think about prior to launch. It emphasizes three key areas of consideration: education across the care continuum, coordination of continuity of care and team management, and facilitation of coding, billing, and economics. SITC continues to work collaboratively with ACCC on disseminating the resource emphasizing distribution to the community cancer center audience. 

World Immunotherapy Council (WIC)

The World Immunotherapy Council’s 5th Young Investigator Symposium featured 16 of the top young investigators from over 13 countries worldwide. SITC is honored to host this collaborative and diverse program on behalf of the WIC during its Annual Meeting.

Hiroyasu Aoki, MD, PhD Student
Japanese Association of Cancer Immunology (JACI)

Vincent Chien-Huai Chuang
The Taiwanese Oncology Society (TOS)

Anirban Das, MD
Canadian Cancer Immunotherapy Consortium (CCIC)

Gloria Delfanti, PhD
Italian Network for Tumor Biotherapy (NIBIT)

Paulien Kaptein, PhD student
KWF Dutch Tumor Immunology Meeting (KWF-DTIM)

Evangelos Koustas, MD, PhD
University of Athens (National Greek Organization)

Geoffrey Markowitz, PhD
Society for Immunotherapy of Cancer (SITC)

Margaret Ottaviano MD, PhD
Società Campana di ImmunoTerapia Oncologica (SCITO)

Mykyta Pepenin, MD
Ukraine (Peace and Development Foundation)

Lorena Pérez-Amill, PhD
Spanish Group of Immuno-Biological Therapeutics in Cancer (GETICA)

Parthiban Periasamy, PhD
Singapore Society of Oncology - Cancer Immunotherapy Consortium (SSO-CIC)

Lamberto Torralba Raga, PhD
Scandinavian Network for Immunotherapy of Cancer (SNIC)

Federica Riccardo, PhD
Progress in Vaccination Against Cancer (PIVAC)

Zaigham Abbas Rizvi, PhD
Immuno-Oncology Society of India (I-OSI)

Lesley Wu, MD
Chinese American Hematology Oncology Network (CAHON)

Jiachen Xu, MD
Chinese Society for Clinical Oncology (CSCO)